Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697538 · ClinicalTrials.gov registry record · NA
Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03697538: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT03697538 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03697538, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1:1 for the treatment groups. The investigators seek to determine if femoral nerve block (FNB) improves the quality of recovery and improve postoperative analgesia compared with adductor canal block (ACBs) for patients undergoing revision total knee arthroplasty.
Interventions
- PROCEDURE Nerve Block for pain control post-revision total knee arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2022-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03697538
The ClinicalTrials.gov registry entry for NCT03697538 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nerve Block for pain control post-revision total knee arthroplasty is the first listed.
NCT03697538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03697538 about?
NCT03697538 is a clinical study titled "Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty". This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1:1 for the treatment groups. The investigators seek to determine if femoral nerve block (FNB) improves the quality of recovery and improve postoperative analgesia compared with adductor canal block (A...
What is the current status of trial NCT03697538?
This trial is currently terminated. It is a NA study. The enrollment target is 51 participants. The study started on 2018-10-10. Estimated completion is 2022-06-27.
What interventions are being tested in trial NCT03697538?
The interventions under investigation include: Nerve Block for pain control post-revision total knee arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT03697538?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.